News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EBS Lands CE Mark, $3.9 Million for Deep-Brain Vision Loss Treatment


6/7/2013 8:54:50 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EBS Technologies lands CE Mark approval and $3.9 million for its Next Wave deep-brain stimulation device for treating impaired vision. EBS Technologies said it won CE Mark approval in the European Union – plus a cool $3.9 million in Series B financing – for its Next Wave deep-brain stimulation device, touting positive clinical data on the way. The Berlin-based medical device company said it will put much of the cash toward the roll-out of the Next Wave DBS device, which is designed to reverse vision impairment caused by brain injury and stroke.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES